Bill Ackman likes to hold stocks long term, investing in turnaround stories and underappreciated assets. Two of its big investments have seen deteriorating results in 2025, leading Pershing Square’s team to exit its positions.
Source: https://www.fool.com/investing/2025/12/22/billionaire-bill-a…
Contrary to what investors have seen this earnings season, earnings growth is traditionally one of the key indicators of stock price growth. For calendar year 2026, FactSet forecasts earnings growth of companies in the S&P 500 to come in at 15%.
Microsoft is a terrific growth stock with an excellent dividend program. Johnson & Johnson and Coca-Cola are both outstanding dividend payers.
Eli Lilly is at the forefront of the GLP-1 weight loss drug market. The company’s leading position is already being tested by Novo Nordisk’s GLP-1 weight loss pill.
